文献速递主动脉外科

术前肌少症预示胸降主动脉瘤修复术后结局更差

Preoperative Sarcopenia Portends Worse Outcomes After Descending Thoracic Aortic Aneurysm Repair.
PubMed 文献 · Ann Thorac Surg · 2018-06-23

该研究利用总腰大肌面积指数(TPAI)定义肌少症(TPAI<6.5cm²/m²),分析2007至2015年间386例胸降主动脉瘤修复中282例有术前影像的患者,比较胸主动脉腔内修复(TEVAR)与开放手术(OSR)后结局。肌少症患者不良事件显著增加,且与长期死亡率相关;作者认为解剖可行时肌少症患者应考虑TEVAR。

要点

  • 肌少症定义为TPAI<6.5cm²/m²,在OSR组占57%、TEVAR组占48%。
  • 肌少症患者不良事件增加:TEVAR组41% vs 16%,OSR组49% vs 32%。
  • OSR增加肌少症更严重患者的长期死亡风险。

核心结论

  • 术前肌少症与胸降主动脉瘤修复术后不良事件及长期死亡率显著相关。
  • 作者认为若解剖可行,肌少症患者应考虑TEVAR。

研究设计与样本

  • 回顾性分析2007至2015年间386例胸降主动脉瘤修复中有术前影像的282例患者,其中71例(25%)行TEVAR,211例(75%)行OSR。
  • 肌少症定义为TPAI<6.5cm²/m²,不良事件定义为三种及以上多系统并发症、出院非回家或30天内死亡的复合终点。

主要发现

  • 肌少症患病率在OSR组为57%、TEVAR组为48%(p=0.188)。
  • 肌少症危险因素包括年龄>70岁、女性、大体表面积,遗传性胸主动脉疾病为保护因素。
  • 不良事件在肌少症TEVAR组为41% vs 非肌少症TEVAR组16%(p=0.020),肌少症OSR组为49% vs 非肌少症OSR组32%(p=0.012)。
  • 长期死亡决定因素:年龄增加(PE=0.06,p<0.001)、TPAI作为递减线性函数(PE=0.36,p=0.003)、OSR(PE=2.92,p=0.003)、OSR与TPAI交互作用(PE=-0.34,p=0.010)。
  • 交互项显示OSR增加肌少症更严重患者的长期死亡风险。

临床怎么用

  • 作者认为若解剖可行,肌少症患者应考虑TEVAR。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sarcopenia may be an indicator of frailty. We used the total psoas area index (TPAI) to identify sarcopenia and evaluated the effect of preoperative TPAI on outcomes after descending thoracic aortic aneurysm (DTAA) repair. METHODS: Patients with DTAA between 2007 and 2015 who were undergoing thoracic endovascular aortic repair (TEVAR) and open surgical repair (OSR) with available preoperative imaging were analyzed. Sarcopenia was defined as TPAI <6.5cm2/m2. An adverse event was defined as the composite endpoint of three or more multisystem complications, discharge to other than home, or death within 30 days. RESULTS: A total of 282 of 386 DTAA repairs had imaging available for TPAI measurements; 71 of 282 (25%) patients underwent TEVAR, and 211 of 282 (75%) underwent OSR. Preoperative sarcopenia was similar in the two groups (OSR, 57% vs TEVAR, 48%, p = 0.188). Risk factors for sarcopenia were age >70 years, female sex, and large body surface area, whereas heritable thoracic aortic disease was a protective factor. OSR-treated patients with sarcopenia were older compared with patients without sarcopenia (p < 0.001), whereas TEVAR-treated patients had a similar age category distribution (p = 0.187). Patients with sarcopenia had significantly increased adverse events compared with patients who did not have sarcopenia in both groups (sarcopenia-TEVAR, 41% vs nonsarcopenia-TEVAR, 16%, p = 0.020; sarcopenia-OSR, 49% vs nonsarcopenia-OSR, 32%, p = 0.012). Determinants of long-term mortality were increasing age (parameter estimate [PE], 0.06, p < 0.001), TPAI as a decreasing linear function (PE, 0.36, p = 0.003), OSR (PE, 2.92, p = 0.003), and interaction between OSR and TPAI (PE, -0.34, p = 0.010). The interaction term showed that OSR increases long-term mortality risk in more sarcopenic patients. CONCLUSIONS: Preoperative sarcopenia significantly correlated with postoperative adverse events and long-term mortality after DTAA repair. If anatomically feasible, TEVAR should be considered in sarcopenic patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Tanaka A, Sandhu HK, Al Rstum Z, et al. Preoperative Sarcopenia Portends Worse Outcomes After Descending Thoracic Aortic Aneurysm Repair. Ann Thorac Surg. 2018. PMID: 29944880. doi:10.1016/j.athoracsur.2018.05.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。